Trends in Infectious Keratitis in Taiwan: An Update on Predisposing Factors, Microbiological and Antibiotic Susceptibility Patterns

Infectious keratitis (IK) represents a major cause of corneal blindness. This study aims to investigate the demographics, risk factors, microbiological characteristics and antibiotic susceptibility patterns of IK in Taiwan over the past 15 years. A retrospective population-based study was conducted using the Chang Gung Research Database. Patients with IK were identified by diagnostic codes for corneal ulcer from 2004 to 2019. Of 7807 included subjects, 45.2% of patients had positive corneal cultures. The proportion of contact lens-related IK declined, while that of IK related to systemic diseases grew. The percentage of isolated gram-positive bacteria surpassed that of gram-negative bacteria in the 15-year period. The prevalence of Pseudomonas aeruginosa showed a decreasing trend (p = 0.004), whereas coagulase-negative Staphylococcus (CNS) and Propionibacterium species were increasingly detected (p < 0.001). Overall, the trend of antibiotic susceptibility of both gram-positive and gram-negative bacteria did not change throughout the study period. The susceptibility to the test antibiotics maintained over 90% in gram-negative isolates over 15 years. Vancomycin preserved 100% susceptibility to all gram-positive isolates. Since most tested antibiotics exhibited stable susceptibility over decades, this study reinforced that fluoroquinolones and fortified vancomycin continue to be good empiric therapies for treating bacterial keratitis in Taiwan.

[1]  Kai Cao,et al.  Pathogens and Antibiotic Susceptibilities of Global Bacterial Keratitis: A Meta-Analysis , 2022, Antibiotics.

[2]  V. Jhanji,et al.  Speciation and Antibiotic Susceptibilities of Coagulase Negative Staphylococci Isolated from Ocular Infections , 2021, Antibiotics.

[3]  E. Pearlman,et al.  American Academy of Optometry Microbial Keratitis Think Tank , 2021, Optometry and vision science : official publication of the American Academy of Optometry.

[4]  Reza Mirshahi,et al.  Infectious keratitis: trends in microbiological and antibiotic sensitivity patterns , 2021, Eye.

[5]  H. Dua,et al.  Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance , 2021, Eye.

[6]  Chi-Chin Sun,et al.  Epidemiology and the Estimated Burden of Microbial Keratitis on the Health Care System in Taiwan: A 14-Year Population-Based Study. , 2020, American journal of ophthalmology.

[7]  H. Dua,et al.  12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study , 2020, British Journal of Ophthalmology.

[8]  Monica Lahra,et al.  Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  B. Söderquist,et al.  Infectious keratitis: isolated microbes and their antibiotic susceptibility pattern during 2004–2014 in Region Örebro County, Sweden , 2019, Acta ophthalmologica.

[10]  F. Stapleton,et al.  Trends in contact lens microbial keratitis 1999 to 2015: a retrospective clinical review , 2019, Clinical & experimental ophthalmology.

[11]  Monica Lahra,et al.  Microbial Keratitis and Ocular Surface Disease: A 5-Year Study of the Microbiology, Risk Factors and Clinical Outcomes in Sydney, Australia , 2019, Current eye research.

[12]  D. Robertson,et al.  The impact of hyperglycemia on the corneal epithelium: Molecular mechanisms and insight. , 2019, The ocular surface.

[13]  Huimin Zhong,et al.  How Ocular Surface Microbiota Debuts in Type 2 Diabetes Mellitus , 2019, Front. Cell. Infect. Microbiol..

[14]  M. Gilmore,et al.  The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance. , 2019, Survey of ophthalmology.

[15]  I. Wang,et al.  Microbial Keratitis in Taiwan: A 20-Year update. , 2019, American journal of ophthalmology.

[16]  F. Stapleton,et al.  Queensland Microbial Keratitis Database: 2005–2015 , 2019, British Journal of Ophthalmology.

[17]  J. Mehta,et al.  The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia. , 2018, American journal of ophthalmology.

[18]  Lixin Xie,et al.  Clinical analysis of fungal keratitis in patients with and without diabetes , 2018, PloS one.

[19]  Saurabh Ghosh,et al.  A 10-year analysis of microbiological profiles of microbial keratitis: the North East England Study , 2018, Eye.

[20]  F. Falcão-Reis,et al.  Clinical and Microbiological Profile of Bacterial Microbial Keratitis in a Portuguese Tertiary Referral Center—Where Are We in 2015? , 2016, Eye & contact lens.

[21]  C. Cui,et al.  A comparative study of risk factors for corneal infection in diabetic and non-diabetic patients. , 2018, International journal of ophthalmology.

[22]  A. Lichtinger,et al.  Bacterial Keratitis in Toronto: A 16-Year Review of the Microorganisms Isolated and the Resistance Patterns Observed , 2017, Cornea.

[23]  Hans Limburg,et al.  Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. , 2017, The Lancet. Global health.

[24]  Jhi-Joung Wang,et al.  Risk of corneal ulcer in patients with end-stage renal disease: a retrospective large-scale cohort study , 2017, British Journal of Ophthalmology.

[25]  Stefano Bonini,et al.  TFOS DEWS II pathophysiology report. , 2017, The ocular surface.

[26]  C. Fullwood,et al.  Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital , 2017, Eye.

[27]  A. Elliot,et al.  Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[28]  J. Ram,et al.  Shifting Trends in Bacterial Keratitis in Taiwan: A 10-Year Review in a Tertiary-Care Hospital. , 2016, Cornea.

[29]  S. Tseng,et al.  Risk of Band Keratopathy in Patients with End-Stage Renal Disease , 2016, Scientific Reports.

[30]  D. Stone,et al.  Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014 , 2016, Cornea.

[31]  R. Malik,et al.  Early Corneal Cellular and Nerve Fiber Pathology in Young Patients With Type 1 Diabetes Mellitus Identified Using Corneal Confocal Microscopy. , 2016, Investigative ophthalmology & visual science.

[32]  H. D. Cavanagh,et al.  Microbial Keratitis at an Urban Public Hospital: A 10-Year Update , 2015, Journal of clinical & experimental ophthalmology.

[33]  Michael J. Beach,et al.  Estimated Burden of Keratitis — United States, 2010 , 2014, MMWR. Morbidity and mortality weekly report.

[34]  H. Goossens,et al.  Antibiotic resistance—the need for global solutions , 2013, BDJ.

[35]  N. Sharma,et al.  Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. , 2013, Ophthalmology.

[36]  J. Jamart,et al.  Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. , 2012, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[37]  J. Y. Ku,et al.  Shifting trends in bacterial keratitis in Toronto: an 11-year review. , 2012, Ophthalmology.

[38]  A. Gurbaxani,et al.  Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom. , 2011, Ophthalmology.

[39]  T. Morris,et al.  Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study. , 2011, American journal of ophthalmology.

[40]  A. Pandita,et al.  Microbial keratitis in Waikato, New Zealand , 2011, Clinical & experimental ophthalmology.

[41]  S. Hornby,et al.  In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review , 2011, Eye.

[42]  R. Redfern,et al.  Toll-like receptors in ocular surface disease. , 2010, Experimental Eye Research.

[43]  I. Cree,et al.  Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study , 2009, British Journal of Ophthalmology.

[44]  D. Ritterband,et al.  The Prevalence and Pathogenicity of Propionibacterium acnes Keratitis , 2009, Cornea.

[45]  M. Raizman,et al.  Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. , 2008, American journal of ophthalmology.

[46]  F. Stapleton,et al.  Risk Factors and Causative Organisms in Microbial Keratitis , 2008, Cornea.

[47]  Lindsay Brown Resistance to ocular antibiotics: an overview , 2007, Clinical & experimental optometry.

[48]  Yu-Chih Hou,et al.  Clinical characteristics of microbial keratitis in a university hospital in Taiwan. , 2004, American journal of ophthalmology.

[49]  C. K. Gurung,et al.  The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal , 2001, The British journal of ophthalmology.

[50]  M. Srinivasan,et al.  Corneal blindness: a global perspective. , 2001, Bulletin of the World Health Organization.

[51]  G. Alexandrakis,et al.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.

[52]  J. Erie,et al.  Incidence of ulcerative keratitis in a defined population from 1950 through 1988. , 1993, Archives of ophthalmology.